| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009114599 |
| P356 | DOI | 10.1007/S12185-013-1421-X |
| P698 | PubMed publication ID | 23982970 |
| P2093 | author name string | Yoshinobu Maeda | |
| P2860 | cites work | Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality | Q28509235 |
| NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses | Q28588300 | ||
| Molecular identification of a danger signal that alerts the immune system to dying cells | Q29619497 | ||
| Divergence of quaternary structures among bacterial flagellar filaments | Q30446018 | ||
| Heat shock protein 70: correlation of expression with degree of graft-versus-host response and clinical graft-versus-host disease1 | Q33193121 | ||
| Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies | Q33401314 | ||
| Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation | Q33615249 | ||
| Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD | Q35084400 | ||
| Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model | Q35525740 | ||
| Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation | Q35673668 | ||
| Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity | Q35691842 | ||
| Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease | Q35995245 | ||
| LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation | Q36028584 | ||
| Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide | Q36078180 | ||
| An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues | Q36228795 | ||
| Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation | Q36305350 | ||
| Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. | Q36330867 | ||
| Implications of TNF-α in the pathogenesis and management of GVHD | Q36370782 | ||
| TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection | Q36941127 | ||
| Activation of the innate immune system by the endogenous ligand hyaluronan | Q37228248 | ||
| NOD2 regulates hematopoietic cell function during graft-versus-host disease | Q37377427 | ||
| Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease | Q37388077 | ||
| Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality | Q37460355 | ||
| The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer | Q37487325 | ||
| Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors | Q37665086 | ||
| Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9. | Q39878275 | ||
| Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation | Q40516766 | ||
| Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. | Q42794018 | ||
| MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease | Q42966829 | ||
| Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. | Q44848328 | ||
| High-mobility group box 1 (HMGB1) as a master regulator of innate immunity | Q45863504 | ||
| Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children | Q46297998 | ||
| Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease | Q47371499 | ||
| The biology of graft-versus-host reactions | Q47809350 | ||
| Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation. | Q51785979 | ||
| P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. | Q53571198 | ||
| Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. | Q54620738 | ||
| Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population. | Q54636018 | ||
| Human CD4+ T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4+CD25+ T Regulatory Cells | Q57447880 | ||
| Salivary Proteomic Analysis and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation | Q60464156 | ||
| Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation | Q62658643 | ||
| Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation | Q62658651 | ||
| Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation | Q74444949 | ||
| Prevention of graft versus host disease by inactivation of host antigen-presenting cells | Q78016071 | ||
| CD44-hyaluronic acid interactions mediate shear-resistant binding of lymphocytes to dermal endothelium in acute cutaneous GVHD | Q79077287 | ||
| "Secondary disease" of radiation chimeras: a syndrome due to lymphoid aplasia | Q79585828 | ||
| Critical role of TLR9 in acute graft-versus-host disease | Q79675206 | ||
| No impact of NOD2/CARD15 on outcome after SCT | Q80813551 | ||
| HSP70-hom gene polymorphism in allogeneic hematopoietic stem-cell transplant recipients correlates with the development of acute graft-versus-host disease | Q81628613 | ||
| Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination | Q82312167 | ||
| Successful treatment of refractory acute GVHD complicated by severe intestinal transplant-associated thrombotic microangiopathy using recombinant thrombomodulin | Q83286523 | ||
| Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system | Q84260223 | ||
| P433 | issue | 3 | |
| P921 | main subject | pathogenesis | Q372016 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 293-299 | |
| P577 | publication date | 2013-08-28 | |
| P1433 | published in | International Journal of Hematology | Q6051416 |
| P1476 | title | Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses | |
| P478 | volume | 98 |
| Q41070167 | A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation. |
| Q38689056 | Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation |
| Q39013210 | Curative haploidentical BMT in a murine model of X-linked chronic granulomatous disease. |
| Q91010169 | Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation |
| Q33618681 | Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation |
| Q55311740 | Eosinophils from Physiology to Disease: A Comprehensive Review. |
| Q44128066 | Guest editorial: new basic and clinical aspects of graft-versus-host disease: what can we do without ‘‘Doc’’ Brown’s help? |
| Q57466793 | Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation |
| Q57818274 | Infection Complications in Hematopoietic Stem Cells Transplant Recipients: Do Genetics Really Matter? |
| Q38309267 | Innate immunity for better or worse govern the allograft response |
| Q35587907 | Intestinal microbiota-related effects on graft-versus-host disease. |
| Q34487408 | Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. |
| Q38502469 | Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome? |
| Q38753771 | Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation |
| Q38416371 | Prophylactic and therapeutic treatment of graft-versus-host disease in Japan |
| Q50062411 | TAK1 inhibition ameliorates survival from graft-versus-host disease in an allogeneic murine marrow transplantation model |
| Q35609254 | The Free Radical Scavenger NecroX-7 Attenuates Acute Graft-versus-Host Disease via Reciprocal Regulation of Th1/Regulatory T Cells and Inhibition of HMGB1 Release. |
| Q59130037 | Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease |
| Q40209654 | Toll-like receptor genetic variations in bone marrow transplantation. |
Search more.